Algo version: 0.98b
Wakamoto Pharmaceutical is listed at the JPX Exchange
Wakamoto Pharmaceutical [4512.T]
JPX Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Wakamoto Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Wakamoto Pharmaceutical pays dividends. Last time was Friday 28th of June 2024 where the investors holding the stock on Thursday 28th of March 2024 were paid JPY3 per share. Over the last 18 times between 2001 and 2024, Wakamoto Pharmaceutical has paid JPY48.5 with an average of JPY2.69 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Wakamoto Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY243.00, you would have made a profit of JPY3.00 per share or 1.23%

Yes, the average daily trading liquidity for Wakamoto Pharmaceutical is JPY47 012 thousand. You should therefore be able to get in and out of your positions relatively fast.

Wakamoto Pharmaceutical has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 8.16, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Wakamoto Pharmaceutical to be low [0.3 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.